Gaucher Disease, Type 2
3 clinical trials · Condition
◉ Watch Gaucher Disease, Type 2
| Record | Firm | Date |
|---|---|---|
| PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) (NCT04532047) | University of California, San Francisco | 2021-07-01 |
| Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) (NCT04411654) | Prevail Therapeutics | 2021-06-29 |
| Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2 (NCT04470713) | Idorsia Pharmaceuticals Ltd. | 2019-07-31 |
Track Gaucher Disease, Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.